Focus on Innovation
Graviti Pharmaceuticals is committed to be an innovative pharmaceuticals R&D company. With an aim to develop specialized molecules that deliver the highest value to customers, the company invests almost 8% of it’s revenue for R&D. This is significantly higher than the industry benchmark.
The Research and Development (R&D) activities are spear headed up by researchers with proven expertise in numerous drug delivery technologies.
Commitment to Quality
We believe that quality control is indeed crucial for the development of pharmaceutical products.
Graviti Pharmaceuticals strictly adhere to the mandates of ‘Good Manufacturing Practices’ and ‘Quality by Design’, thus ensuring product integrity, quality, process control, minimized exposure to risks and increased regulatory compliance.
This risk based approach and process analytical technology initiative assures product quality through design and performance-based specifications.
Culture of Value
Building on the Group’s remarkable track record, Graviti Pharmaceuticals focuses on providing affordable generic drugs to patients and the communities worldwide. By providing superior quality generic drugs, we aim to lower the cost of healthcare and help care givers deliver effective and affordable treatment solutions.
We believe in forging long term relationships by being transparent, trustworthy and accountable. Our dedicated Partnership Management Team is committed to be responsive to client’s requirements, through smooth communication and seamless integration at all stages of the project.
- Young and agile firm focused on accelerated execution
- World-class R&D and manufacturing facilities
- Strong team of researchers and business leaders fuelling innovation and efficiency
- Wide array of delivery systems
- Strict adherence to GMP & ‘Quality by Design’ processes